Telomere Length, Mean Leukocyte
8
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?
Mitigating Heat Stress Among Rickshaw Drivers in Bangladesh
Stress Management and Biological Age in Breast Cancer Patients.RCT
Pediatric ACEs Screening and Resiliency Study
Telomere Disclosure and Impact on Psychological Distress and Health Behaviors
Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to Telomeropathy
Diet Quality and LTL in NHANES
Rosuvastatin Effect on Telomere-telomerase System in ACS